Skip to content

Berberine vs Ozempic

Share this article

Listen to this article on Spotify, or watch it on YouTube.

Dubbed as “nature’s Ozempic” by social media, berberine is supposed to be a natural form of Ozempic. But how exactly does berberine and Ozempic compare? And can it actually replicate Ozempic’s effects?

Let’s dive into the similarities and differences between Ozempic, and this so-called “nature’s Ozempic”.

Where they originate from

Berberine, a naturally occurring chemical, can be found in various herbs such as European barberry, goldenseal, goldthread, greater celandine, and Oregon grape.

In fact, a lot of these herbs owe a significant part of their beneficial properties to the presence of berberine.

So if you’ve ever heard about any of these herbs, you might find it more effective to just directly take berberine, instead of opting for a crude extract or tincture derived from one of these plants.

Ozempic is the popular medication semaglutide—a synthetic drug developed by Novo Nordisk.

Semaglutide serves as the foundation for several similar medications, such as Wegovy, which is the high-dose weight loss version of Ozempic, and Rybelsus, which is the oral or pill form of Ozempic.

It’s worth mentioning that Ozempic is injected, while berberine is typically not taken in this manner. So, if we’re being nitpicky, we should really be comparing berberine with Rybelsus, which is taken as a pill like berberine. But let’s not get too caught up in technicalities.

Berberine vs Ozempic

It’s somewhat odd to me to compare berberine to Ozempic because they work completely differently, and engage different receptors, which cause completely different actions.

berberine-vs-ozempic-for-diabetes-and-weight-loss
Comparing berberine to Ozempic.

Berberine operates primarily by activating a protein called AMP-activated protein kinase (AMPK). Although its actions on the receptor are relatively weak, the activation of AMPK reduces glucose levels in the bloodstream and lowers cholesterol levels.

On the other hand, Ozempic stimulates the Glucagon-like peptide-1 receptor (GLP-1), and is considered a strong GLP-1 agonist. This activation of GLP-1 triggers two significant responses: the release of insulin and the slowing down of our digestive system.

Blood sugar control

When it comes to managing blood sugar in individuals with diabetes, both berberine and Ozempic offer potential benefits.

Both substances are helpful for glucose control by reducing high glucose levels. However, their effectiveness and approaches to lowering blood sugar differ.

Berberine primarily slows down glucose production in the liver and encourages the body to utilize more glucose from the bloodstream.

On the other hand, Ozempic not only reduces glucose production in the liver but also directly increases insulin secretion.

Because insulin is a very strong mediator of glucose control, Ozempic yields a more substantial overall impact, surpassing berberine in its ability to lower blood sugar and HbA1c levels.

Research indicates that berberine can reduce HbA1c levels by approximately 0.6%, while Ozempic achieves a reduction of 1.5%. This means that Ozempic may be two to three times more effective in treating diabetes compared to berberine.

Nevertheless, it’s worth noting that berberine’s performance is commendable considering it is an over-the-counter supplement, and costs around $20 to $30 per month.

In contrast, Ozempic requires a doctor’s prescription and can cost close to $1000 per month without insurance coverage.

So when it comes to blood sugar control, berberine does hold its own, considering the cost-effectiveness and availability, making it a potentially natural version of Ozempic for diabetics.

Weight loss

When it comes to weight loss however, the certainty of berberine’s effects on weight are far less established.

Berberine mainly focuses on reducing blood sugar levels, which, in turn, helps to reduce fat production associated with high blood sugar. Additionally, it has some anti-inflammatory properties.

However, these effects are considered indirect when it comes to weight loss, as they don’t directly impact calorie intake or expenditure.

As a result, berberine’s effect on weight loss may be limited, especially since it doesn’t have much effect on appetite.

On the other hand, Ozempic directly affects calorie intake by suppressing appetite, slowing down digestion, and preventing people from eating too much at all. Furthermore, it enhances feelings of fullness, particularly in relation to higher calorie fatty foods.

These effects are regarded as direct contributors to weight loss, as they directly reduce the amount of calories consumed. As a result, Ozempic will be much more effective at reducing calorie intake and causing weight loss.

Research indicates that berberine may lead to a weight reduction of approximately 5 lbs in the most favorable scenarios, whereas Ozempic, depending on the dosage used, can result in a weight loss of about 12 to 20 lbs.

Additionally, this comparison between berberine and Ozempic is subject to a significant caveat.

Most studies investigating the weight loss effects of berberine focus on individuals with diabetes or PCOS, rather than healthy individuals. In contrast, semaglutide has been tested both in diabetics and in healthy individuals.

This means that Ozempic is not only more effective, but will be more effective for a broader range of individuals, including those who are generally healthy, while berberine may only be effective for weight loss in individuals with blood sugar-related problems, like diabetics or those with PCOS.

Is berberine natural Ozempic?

So is the term “Nature’s Ozempic” an accurate description? Not quite. But my assessment is primarily based on how these substances function and their sources, rather than a direct comparison of their effectiveness.

It’s expected that the natural form of any drug would be weaker and less potent than its purified synthetic counterpart.

However, berberine and Ozempic operate differently and are not structurally similar compounds. And while both are sometimes used for blood sugar control in diabetics, berberine is unlikely to aid in weight loss for your average healthy individual.

Is berberine a GLP-1 agonist?

Now there have been some studies suggesting that berberine might have an impact on GLP-1 and potentially act as a GLP-1 agonist.

This has led to speculation that berberine could mimic the effects of Ozempic, which is a GLP-1 agonist itself.

However, all these studies have been conducted on lab animals and cells in petri dishes, not humans. Therefore, we lack any evidence to support the notion that berberine actually affects GLP-1 levels in the human body.

Also, the proposed mechanism for this increase, is that berberine might slightly increase the body’s own secretion of GLP-1, rather than directly activating GLP-1 itself. This is a subtle but significant difference.

Substances that boost the body’s natural hormone secretion typically operate within tightly regulated limits.

The human body is finely tuned to prevent excessive production of any given hormone, as it could lead to severe complications.

Even if we assume that berberine could enhance the body’s secretion of GLP-1, the maximum increase would likely be minimal, insufficient to have much effect on appetite or digestion.

In contrast, drugs like semaglutide, which directly activate GLP-1, have no such limitations.

They can be administered in any desired quantity, essentially flooding the body to create effects that would otherwise be impossible through the body’s natural GLP-1 production alone.

So the speculation that berberine could somehow replicate the effects of Ozempic as a natural alternative is not true.

Even if berberine were to increase GLP-1 production, the body would stop producing it long before it reaches the amounts required to replicate Ozempic’s effects.

Berberine vs metformin

In my view, a more fitting name for berberine would be “nature’s metformin,” as it shares a closer relationship with the diabetes medication metformin.

berberine-vs-metformin-for-diabetes-and-weight-loss
Comparing berberine to metformin.

Both berberine and metformin operate in similar ways as activators of AMPK, offering comparable health benefits. However, metformin is a more potent AMPK activator.

Numerous studies have compared the effects of berberine and metformin on blood sugar control in diabetics and found them to be quite similar.

However, metformin appears to have a significantly greater impact on HbA1c, a long-term measurement of blood sugar control.

This suggests that while both berberine and metformin have similar short-term benefits on blood sugar, metformin likely proves more effective in the long-term management and treatment of diabetes.

Regarding weight loss effects, both substances are quite similar and primarily help individuals with diabetes in shedding some weight.

However, when it comes to cholesterol control, berberine seems to hold an advantage over metformin. The majority of evidence suggests that berberine is better at lowering cholesterol levels compared to metformin.

Additionally, individuals taking berberine tend to experience fewer side effects and overall have better tolerance compared to those on metformin.

Should you take “nature’s Ozempic”?

Ultimately, whether berberine can be considered “nature’s Ozempic” largely depends on your expectations and goals for taking berberine.

If your intention is to lose weight, particularly with hopes of achieving similar effectiveness to Ozempic, you’ll probably be disappointed.

Ozempic far surpasses berberine in its ability to suppress appetite and induce weight loss. Even for diabetics, the weight loss achieved with berberine is likely to be minimal compared to Ozempic.

Keep in mind that berberine and Ozempic function in completely different ways, despite both potentially being helpful for diabetics, which is why I find comparing both of them to be somewhat strange.

However, if you’re a diabetic seeking assistance with blood sugar control, berberine is a potential natural alternative, and perhaps using the term “nature’s Ozempic” in this case would be more appropriate.

So while berberine may have its benefits, expecting it to replicate Ozempic or serve as a some sort of substitute, particularly for weight loss, will likely lead to disappointment.

Top supplement choices

Learn more about

Citations

An Y, Sun Z, Zhang Y, Liu B, Guan Y, Lu M. The use of berberine for women with polycystic ovary syndrome undergoing IVF treatment. Clin Endocrinol (Oxf) 2014;80(3):425-31.

Asbaghi O, Ghanbari N, Shekari M, et al. The effect of berberine supplementation on obesity parameters, inflammation and liver function enzymes: A systematic review and meta-analysis of randomized controlled trials. Clin Nutr ESPEN. 2020;38:43-49. doi:10.1016/j.clnesp.2020.04.010

Dong H, Zhao Y, Zhao L, Lu F. The effects of berberine on blood lipids: a systemic review and meta-analysis of randomized controlled trials. Planta Med 2013;79(6):437-46.

Doggrell SA. Berberine–a novel approach to cholesterol lowering. Expert Opin Investig Drugs. 2005;14(5):683-685. doi:10.1517/13543784.14.5.683

Frías JP, Auerbach P, Bajaj HS, et al. Efficacy and safety of once-weekly semaglutide 2·0 mg versus 1·0 mg in patients with type 2 diabetes (SUSTAIN FORTE): a double-blind, randomised, phase 3B trial. Lancet Diabetes Endocrinol. 2021;9(9):563-574. doi:10.1016/S2213-8587(21)00174-1

Guo J, Chen H, Zhang X, et al. The Effect of Berberine on Metabolic Profiles in Type 2 Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Oxid Med Cell Longev. 2021;2021:2074610. Published 2021 Dec 15. doi:10.1155/2021/2074610

Hui F, Zhang Y, Ren T, Li X, Zhao M, Zhao Q. Role of metformin in overweight and obese people without diabetes: a systematic review and network meta-analysis. Eur J Clin Pharmacol. 2019;75(4):437-450. doi:10.1007/s00228-018-2593-3

Ju J, Li J, Lin Q, Xu H. Efficacy and safety of berberine for dyslipidaemias: A systematic review and meta-analysis of randomized clinical trials. Phytomedicine. 2018;50:25-34. doi:10.1016/j.phymed.2018.09.212

Kong, W., Wei, J., Abidi, P., Lin, M., Inaba, S., Li, C., Wang, Y., Wang, Z., Si, S., Pan, H., Wang, S., Wu, J., Wang, Y., Li, Z., Liu, J., and Jiang, J. D. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat Med 2004;10(12):1344-1351.

Koppen LM, Whitaker A, Rosene A, Beckett RD. Efficacy of Berberine Alone and in Combination for the Treatment of Hyperlipidemia: A Systematic Review. J Evid Based Complementary Altern Med. 2017 Oct;22(4):956-968. doi: 10.1177/2156587216687695. Epub 2017 Jan 16. PMID: 29228784; PMCID: PMC5871262.

Lan J, Zhao Y, Dong F, et al. Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension. J Ethnopharmacol. 2015;161:69-81.

Lu SS, Yu YL, Zhu HJ, et al. Berberine promotes glucagon-like peptide-1 (7-36) amide secretion in streptozotocin-induced diabetic rats. J Endocrinol. 2009;200(2):159-165. doi:10.1677/JOE-08-0419

Pentikäinen PJ, Voutilainen E, Aro A, Uusitupa M, Penttilä I, Vapaatalo H. Cholesterol lowering effect of metformin in combined hyperlipidemia: placebo controlled double blind trial. Ann Med. 1990;22(5):307-312. doi:10.3109/07853899009147912

Seifarth C, Schehler B, Schneider HJ. Effectiveness of metformin on weight loss in non-diabetic individuals with obesity. Exp Clin Endocrinol Diabetes. 2013;121(1):27-31. doi:10.1055/s-0032-1327734

Sorli C, Harashima SI, Tsoukas GM, et al. Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial. Lancet Diabetes Endocrinol. 2017;5(4):251-260. doi:10.1016/S2213-8587(17)30013-X

Wang H, Zhu C, Ying Y, Luo L, Huang D, Luo Z. Metformin and berberine, two versatile drugs in treatment of common metabolic diseases. Oncotarget. 2017 Sep 11;9(11):10135-10146. doi: 10.18632/oncotarget.20807. PMID: 29515798; PMCID: PMC5839379.

Wei, W., Zhao, H., Wang, A., Sui, M., Liang, K., Deng, H., Ma, Y., Zhang, Y., Zhang, H., and Guan, Y. A clinical study on the short-term effect of berberine in comparison to metformin on the metabolic characteristics of women with polycystic ovary syndrome. Eur J Endocrinol. 2012;166(1):99-105.

Yaribeygi H, Jamialahmadi T, Moallem SA, Sahebkar A. Boosting GLP-1 by Natural Products. Adv Exp Med Biol. 2021;1328:513-522. doi:10.1007/978-3-030-73234-9_36

Yerevanian A, Soukas AA. Metformin: Mechanisms in Human Obesity and Weight Loss. Curr Obes Rep. 2019;8(2):156-164. doi:10.1007/s13679-019-00335-3

Yin, J., Xing, H., and Ye, J. Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism 2008;57(5):712-717.

Yu Y, Hao G, Zhang Q, et al. Berberine induces GLP-1 secretion through activation of bitter taste receptor pathways. Biochem Pharmacol. 2015;97(2):173-177. doi:10.1016/j.bcp.2015.07.012

Zhang Y, Li X, Zou D, et al. Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine. J Clin Endocrinol Metab 2008;93:2559-65.

Zhang, H., Wei, J., Xue, R., Wu, J. D., Zhao, W., Wang, Z. Z., Wang, S. K., Zhou, Z. X., Song, D. Q., Wang, Y. M., Pan, H. N., Kong, W. J., and Jiang, J. D. Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression. Metabolism 2010;59(2):285-292.

Zhang LS, Zhang JH, Feng R, et al. Efficacy and safety of berberine alone or combined with statins for the treatment of hyperlipidemia: a systematic review and meta-analysis of randomized controlled clinical trials. Am J Chin Med 2019;47(4):751-67.


See also


Share this article

Leave a Reply

Your email address will not be published. Required fields are marked *